Consensus Teleflex Incorporated

Stocks

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 16:00:02 2026-10-27 EDT			5-day change	1st Jan Change
139.00 ^USD	+1.61%		+5.99%	+13.90%

10-22	Teleflex Wins FDA Breakthrough Designation for Resorbable Heart Scaffold	MT
10-22	Teleflex Incorporated Announces Fda Breakthrough Device Designation for Freesolve Resorbable Magnesium Scaffold	CI

Evolution of the Average Target: Teleflex Incorporated

Evolution of the Target Price: Teleflex Incorporated

Changes in Analyst Recommendations: Teleflex Incorporated

3.APzKLcjVjf9rSg6e_j3sPqPbAu9_eJxf-xSUHYS_75k.OLeeWabi_LEkD1bpoUfBavWLV74cCapst06mMMjWn9NDrZJime3psyo7Sw~757b841b339c61daae5c2a2f98604dcf

Analysts' recommendations: Teleflex Incorporated

10-14	Truist Securities Adjusts Teleflex Price Target to $142 From $150, Maintains Hold Rating	MT
09-28	Teleflex Growth Prospects, New Leadership Could Drive 2027 Re-Rating, BofA Securities Says	MT
09-28	BofA Upgrades Teleflex to Buy From Neutral, Adjusts Price Target to $158 From $145	MT
09-28	BofA Upgrades Teleflex to Buy From Neutral, Price Target is $158	MT
08-25	Needham Adjusts Price Target on Teleflex to $170 From $159, Maintains Buy Rating	MT
08-11	UBS Adjusts Teleflex Price Target to $158 From $145, Maintains Neutral Rating	MT
08-10	Truist Securities Adjusts Price Target on Teleflex to $150 From $143, Keeps Hold Rating	MT
08-07	Teleflex's 2027 Framework is Achievable, RBC Capital Markets Says	MT
07-31	Needham Raises Price Target on Teleflex to $159 From $147, Keeps Buy Rating	MT
07-28	UBS Initiates Coverage on Teleflex With Neutral Rating, $145 Price Target	MT
07-09	BMO Captal Initiates Coverage on Teleflex With Outperform Rating, $159 Price Target	MT
05-08	RBC Upgrades Teleflex to Outperform From Sector Perform, Raises Price Target to $155 From $135	MT
04-14	RBC Raises Price Target on Teleflex to $135 From $125, Keeps Sector Perform Rating	MT
03-27	Raymond James Upgrades Teleflex to Outperform From Market Perform, $128 Price Target	MT
02-27	RBC Capital Adjusts Teleflex Price Target to $125 From $115, Maintains Sector Perform Rating	MT
02-26	Needham Raises Teleflex Price Target to $147 From $138, Buy Rating Kept	MT
01-27	Needham Upgrades Teleflex to Buy From Hold, Sets $138 Price Target	MT
01-20	RBC Cuts Price Target on Teleflex to $115 From $130, Keeps Sector Perform Rating	MT
12-18	Truist Securities Adjusts Price Target on Teleflex to $135 From $120, Maintains Hold Rating	MT
12-17	RBC Adjusts Price Target on Teleflex to $135 From $120, Maintains Sector Perform Rating	MT
11-10	Truist Cuts Price Target on Teleflex to $120 From $128, Keeps Hold Rating	MT
11-07	RBC Capital Adjusts Teleflex Price Target to $120 From $135, Maintains Sector Perform Rating	MT
25-08-01	Truist Securities Raises Price Target on Teleflex to $128 From $123, Keeps Hold Rating	MT
25-08-01	RBC Raises Price Target on Teleflex to $135 From $130, Keeps Sector Perform Rating	MT
25-07-15	RBC Cuts Price Target on Teleflex to $130 From $145, Keeps Sector Perform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TELEFLEX INCORPORATED					+12.57%
	ABBOTT LABORATORIES					+13.01%
	STRYKER CORPORATION					+18.45%
	MEDTRONIC PLC					+10.37%
	ESSILORLUXOTTICA					+23.38%
	CENCORA, INC.					+11.84%
	HOYA CORPORATION					+17.29%
	BECTON, DICKINSON AND COMPANY					-0.42%
	IDEXX LABORATORIES, INC.					+22.41%
	ALCON INC.					+29.52%
	Average					+15.84%
	Weighted average by Cap.					+15.23%